ID

28043

Beskrivning

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Past medical conditions

Nyckelord

Versioner (3)

1. 2017-08-27 2017-08-27 -
2. 2017-10-23 2017-10-23 -
3. 2017-12-12 2017-12-12 -

Rättsinnehavare

GlaxoSmithKline

Uppladdad den

12 december 2017

DOI

För en begäran logga in.

Licens